PLK1 and lung cancer: Because the overexpression of EGFR is noted in 50% of patients with lung cancer and the inhibition of the mitotic regulator polo-like kinase 1 (PLK1) can enhance radiation sensitivity, EGFR-positive NSCLC cells were targeted by the siPLK1-NP [102].